ProMetic BioTherapeutics, Inc. – Trademark Portfolio
Entity Type: 03
ProMetic BioTherapeutics, Inc. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. Currently, 1 trademark is registered. Notable registered marks include RYPLAZIM. The owner is based in Rockville, MD.
1330 Piccard Drive, Suite 201
Rockville, MD 20850
Showing of trademarks Trademarks
Trademark Classifications
ProMetic BioTherapeutics, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does ProMetic BioTherapeutics, Inc. have?
ProMetic BioTherapeutics, Inc. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.
What trademark classes does ProMetic BioTherapeutics, Inc. file in?
ProMetic BioTherapeutics, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are ProMetic BioTherapeutics, Inc.'s most well-known trademarks?
ProMetic BioTherapeutics, Inc.'s registered trademark portfolio includes well-known marks such as RYPLAZIM. These are among 1 currently registered trademark in the portfolio.
What is ProMetic BioTherapeutics, Inc.'s trademark registration success rate?
ProMetic BioTherapeutics, Inc. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.